Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu
Trial record 31 of 173 for:    pertuzumab

Phase 2 Study of Standard Chemotherapy With Trastuzumab, Plus or Minus Pertuzumab, for Pre-treated Metastatic Breast Cancer

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT02229149
Recruitment Status : Active, not recruiting
First Posted : August 29, 2014
Last Update Posted : October 1, 2018
Sponsor:
Collaborator:
Genentech, Inc.
Information provided by (Responsible Party):
US Oncology Research

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Active, not recruiting
Estimated Primary Completion Date : December 31, 2019
Estimated Study Completion Date : December 31, 2019